Skip to main content
. 2025 Sep 10;40(1):192. doi: 10.1007/s00384-025-04991-x

Table 1.

Population characteristics

Elderly patients (EPs), n = 30 Young patients (YPs), n = 60 p
Age at diagnosis of Crohn’s disease (years)
Median [IQR 25–75] 67 [62–76] 25 [18.7–32] 0.0001
Age at 1 st surgery in our centers (years)
Median [IQR 25–75] 69 [63–76] 34 [26–40]
Sex ratio M/F 2.0 1.2 0.28
Male, n (%) 20 (66.7%) 33 (55.0%)
Female, n (%) 10 (33.3%) 27 (45.0%)
Comorbidities 24 (80%) 8 (13.3%)  < 0.0001
Diabetes, n (%) 7 (23.3%) 0 (0%) 0.0001
Cardiovascular disease, n (%) 23 (76.7%) 3 (5.0%) 0.0001
- Hypertension 18 (60%) 1 (1.7%) 0.0001
- Ischemic heart disease 6 (20%) 1 (1.7%) 0.0022
- Cardiac rhythm disorder 3 (10%) 2 (3.3%) 0.19
- Peripheral artery disease of the lower limbs 2 (6.7%) 0 (0%) 0.04
- Use of antiplatelet agents 12 (40%) 1 (1.7%) 0.0001
- Use of anticoagulants 3 (10%) 2 (3,3%) 0.19
Cancer, n (%) 9 (30%) 5 (8.3%) 0.008
Kidney failure, n (%) 2 (6.7%) 0 (0%) 0.03
Smoking (n = 86) 0.02
No, n (%) 14 (46.7%) 21(35%)
Former smoker, n (%) 12 (40%) 17 (28.3%)
Yes, n (%) 2 (6.7%) 20 (33.3%)
ASA score 0.02
ASA 1, n (%) 7 (23.3%) 28 (46.7%)
ASA 2, n (%) 14 (46.7%) 27 (45%)
ASA 3, n (%) 9 (30%) 5 (8.3%)
Body mass index (n = 88) 0.10
Median [IQR 25–75] 25.6 [22.7–27.7] 22.6 [20.6–25.9]

IQR interquartile range, EPs age at first surgery ≥ 60; YPs age at first surgery < 60; ASA score American Society of Anesthesiologists score